Human papillomavirus-based cervical cancer prevention: Long-term results of a randomized screening trial

Journal of the National Cancer Institute

Volumn 102, Issue 20, 2010, Pages 1557-1567

  Denny, Lynette ^a   Kuhn, Louise ^b   Hu, Chih Chi ^b   Tsai, Wei Yann ^b   Wright Jr , Thomas C ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Department of Epidemiology Mailman School of Public Health Columbia University ^*  (United States)

^c Department of Biostatistics Mailman School of Public Health Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAINING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; ALPHAPAPILLOMAVIRUS; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; LIFE TABLE; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; SOUTH AFRICA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CRYOTHERAPY; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE TABLES; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SOUTH AFRICA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77958609531     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq342     Document Type: Article

References (34)

1. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):S11-S25.
2. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine. 2006. 24(suppl 3): S3/71-S3/77.
3. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papil-lomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26(suppl 10): K29-K41.
4. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical ben-efts and cost-effectiveness. JAMA. 2001;285(24):3107-3115.
5. Goldie SJ, Gaffkin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in fve developing countries. N Engl J Med. 2005;353(20):2158-2168.
6. Gaffkin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet. 2003;361(9360):814-820.
7. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC Jr. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA. 2005;294(17): 2173-2181.
8. Blumenthal PD, Gaffkin L, Deganus S, Lewis R, Emerson M, Adadevoh S. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007;196(4): e1-e8; discussion 407 e8-e9.
9. Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: an analysis of factors infuencing test performance. Cancer. 2002;94(6):1699-1707.
10. Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC Jr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer. 2000;89(4):826-833. (Pubitemid 30658582)
11. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283(1):81-86.
12. Greenland S. Applications of stratifed analysis methods. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998:286-287.
13. Castle PE, Cox JT, Schiffman M, Wheeler CM, Solomon D. Factors infuencing histologic confrmation of high-grade squamous intraepithe-lial lesion cytology. Obstet Gynecol. 2008;112(3):637-645.
14. Cox JT. More questions about the accuracy of colposcopy: what does this mean for cervical cancer prevention? Obstet Gynecol. 2008;111(6): 1266-1267.
15. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006;108(2):264-272.
16. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of fve cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153-160.
17. Zhang Q, Kuhn L, Denny LA, De Souza M, Taylor S, Wright TC Jr. Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int J Cancer. 2007;120(2):351-356.
18. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385-1394.
19. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398-406.
20. Castro W, Gage JC, Gaffkin L, et al. Effectiveness, Safety, and Acceptability of Cryotherapy: A Systematic Literature Review. Seattle, WA: PATH; 2003.
21. Luciani S, Gonzales M, Munoz S, Jeronimo J, Robles S. Effectiveness of cryotherapy treatment for cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2008;101(2):172-177.
22. Alvarez RD, Helm CW, Edwards RP, et al. Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecol Oncol. 1994;52(2):175-179.
23. Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithe-lial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined signifcance: a two-year prospective study. Am J Obstet Gynecol. 2003;188(6):1401-1405.
24. Suba EJ, Donnelly AD, Furia LM, Huynh ML, Raab SS. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches. Diagn Cytopathol. 2007;35(3):187-191.
25. Wright TC, Hart C, Ellerbrock TV, Lennox J. Treatment of CIN increases vaginal HIV RNA levels. In: 4th Conference on Retroviruses and Opportunistic Infections; January 22-26, 1997; Washington, DC.
26. Myer L, Denny L, De Souza M, Barone MA, Wright TC Jr, Kuhn L. Intravaginal practices, HIV and other sexually transmitted diseases among South African women. Sex Transm Dis. 2004;31(3):174-179.
27. Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis. 2005;192(8):1372-1380.
28. Myer L, Kuhn L, Stein ZA, Wright TC Jr, Denny L. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis. 2005;5(12):786-794.
29. Myer L, Denny L, de Souza M, Wright TC Jr, Kuhn L. Distinguishing the temporal association between women's intravaginal practices and risk of human immunodefciency virus infection: a prospective study of South African women. Am J Epidemiol. 2006;163(6):552-560.
30. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol. 2007;36(1):166-174.
31. Myer L, Kuhn L, Denny L, Wright TC Jr. Recurrence of symptomatic bacterial vaginosis 12 months after oral metronidazole therapy in HIV-positive and-negative women. J Infect Dis. 2006;194(12):1797-1799.
32. Myer L, Wright TC Jr, Denny L, Kuhn L. Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis. 2006;33(11):683-687.
33. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9(10):929-936.
34. Schiffman M, Wacholder S. From India to the world\-a better way to prevent cervical cancer. N Engl J Med. 2009;360(14):1453-1455.